STOCK MARKET BSE NSE

Scientists recommend alternative to Remdesivir amid shortage of key COVID drugs

They said the present work provides a rationale-based approach to select drugs with possible anti-Covid-19 activity for further clinical evaluation.

Published: 12th May 2021 02:47 AM  |   Last Updated: 12th May 2021 09:07 AM   |  A+A-

Vials of remdesivir vaccines recovered from three persons who were arrested by the police for its alleged black marketing, in Kanpur. (Photo | PTI)

For representational purpose. (Photo | PTI)

Express News Service

NEW DELHI:  At a time when the country is facing a shortage of Remdesivir, scientists have investigated 61 antiviral drugs and found a combination that has superior anti-SARS-CoV-2 potential.

A team of scientists from the Biochemical Sciences Division, CSIR-National Chemical Laboratory, India Academy of Scientific and Innovative Research (AcSIR), Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, and INTOX Private Limited, Pune, worked on the efficacy of drug repurposing for treating Covid-19.

“Our analysis suggested Sofosbuvir in combination with Ledipasvir and Daclatasvir as potential therapeutic agents for Covid-19. The combined score suggests that these combinations have superior anti-SARS-CoV-2 potential than Remdesivir and other investigational drugs,” they said in a paper published in Current Science.

They said the present work provides a rationale-based approach to select drugs with possible anti-Covid-19 activity for further clinical evaluation.

With the shortage of Remdesivir, the combination can be used to save the lives of severe Covid-19 patients. 

“Drug repurposing has been utilised as the most preferred therapeutic intervention for Covid mitigation due to its necessity and feasibility. To prioritise therapeutic regime against Covid, we used 61 antiviral drugs and their combinations,” said the paper.

The team said the findings provide a scientific rationale for applying Ledipasvir and Daclatasvir in combination with Sofosbuvir for Covid management.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp